233 related articles for article (PubMed ID: 15522308)
21. Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.
Shirasugi N; Emmanouilidis N; Pearson TC; Larsen CP
Transplant Proc; 2004 Oct; 36(8):2423-4. PubMed ID: 15561267
[TBL] [Abstract][Full Text] [Related]
22. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
[TBL] [Abstract][Full Text] [Related]
23. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.
Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB
J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
25. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
26. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis.
KleinJan A; Willart MA; Kuipers H; Coyle AJ; Hoogsteden HC; Lambrecht BN
Transplantation; 2008 Nov; 86(10):1436-44. PubMed ID: 19034015
[TBL] [Abstract][Full Text] [Related]
27. Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft.
Fukuyama S; Yoshino I; Yamaguchi M; Osoegawa A; Kameyama T; Tagawa T; Maehara Y
Transpl Int; 2005 Oct; 18(10):1203-9. PubMed ID: 16162108
[TBL] [Abstract][Full Text] [Related]
28. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y
J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196
[TBL] [Abstract][Full Text] [Related]
30. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
31. The immunoregulatory roles of natural killer T cells in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Shimizu I; Kajiwara T; Onzuka T; Okano S; Yasunami Y; Yoshikai Y; Nomoto K; Tominaga R
Transplantation; 2007 Dec; 84(12):1686-95. PubMed ID: 18165782
[TBL] [Abstract][Full Text] [Related]
32. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
33. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
[TBL] [Abstract][Full Text] [Related]
34. [Cyclosporin and portal venous inoculation of donor splenocytes prolongs cardiac allograft survival in mice].
Zhou HK; Yu LX; Zheng SB; Min ZL; Zhu YH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1093-5. PubMed ID: 12480604
[TBL] [Abstract][Full Text] [Related]
35. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
[TBL] [Abstract][Full Text] [Related]
36. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
37. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
38. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2009 Nov; 70(5):423-30. PubMed ID: 19874546
[TBL] [Abstract][Full Text] [Related]
39. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
Guo C; Dai K; Tang T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Sueishi K; Nomoto K; Yasui H
Scand J Immunol; 2005 Sep; 62(3):271-80. PubMed ID: 16179014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
